Biodegradable drug-eluting coronary artery stent

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Abbott Vascular Division of Abbott Medical Australia Pty Ltd

classe:

Class I

Fabriqué par:

Abbott Vascular 3200 Lakeside Drive, Santa Clara, CA, 95054 United States Of America

Domaine thérapeutique:

56304 - Biodegradable drug-eluting coronary artery stent

indications thérapeutiques:

The Absorb Bioresorbable Vascular Scaffold is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions. The treated lesion length should be less than the nominal scaffolding length (8 mm, 12 mm, 18 mm, 23 mm, 28 mm) with reference vessel diameters (RVD) ? 2.5 mm and ? 3.75 mm.

Statut de autorisation:

A

Date de l'autorisation:

2017-07-06